Lymphoma

Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma

Canine lymphoma is one of the most common cancers in dogs. While some breeds appear more at risk than others, all can be affected. Although it is often treatable, canine lymphoma can rarely be cured. A continued understanding of the mechanisms causing lymphoma in dogs and identification of novel therapies are needed to improve survival in dogs with lymphoma.

Read more

Discovery of Biomarkers to Detect Lymphoma Risk, Classify For Treatment, and Predict Outcome in Golden Retrievers

Lymphoma strikes 1 in 8 Golden Retrievers, approximately one-third of the cases being B cell.  While T cell classifications currently inform therapy choices for dogs, B cell classifications have been investigated little in Golden Retrievers. 

Read more